FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200517196> ?p ?o ?g. }

• W4200517196 abstract "Insomnia is common in people with long-term medical conditions and is related to increased mortality and morbidity. Cognitive behavioral therapy for insomnia (CBT-I) is first choice treatment and effective for people with insomnia and comorbid long-term medical conditions. However, CBT-I has some limitations as it might not always be available or appeal to patients with medical conditions. Furthermore, a small proportion of patients do not respond to CBT-I. Preliminary evidence and clinical experience suggest that low-dose amitriptyline (AM) might be an effective alternative to treat insomnia in patients with medical comorbidity. In this randomized controlled trial, we will determine whether AM is non-inferior to the first choice treatment for insomnia, CBT-I.This study will test if treatment with low-dose amitriptyline for insomnia in patients with medical comorbidity is non-inferior to CBT-I in a multicenter randomized controlled non-inferiority trial. Participants will be 190 adults with a long-term medical condition and insomnia. Participants will be randomly allocated to one of two intervention arms: 12 weeks AM (starting with 10 mg per day, and if ineffective at 3 weeks, doubling this dose) or 12 weeks of CBT-I consisting of 6 weekly sessions and a follow-up session 6 weeks later. The primary outcome is subjective insomnia severity, measured with the Insomnia Severity Index (ISI). The primary endpoint is at 12 weeks. Secondary outcomes include sleep quality (e.g., sleep efficiency), questionnaires on daytime functioning (physical functioning and impairment of functioning), and symptoms (e.g., fatigue, pain, anxiety) at 12 weeks and 12 months post treatment and relapse of insomnia until 12 months after treatment.Irrespective of the outcome, this study will be a much-needed contribution to evidence based clinical guidelines on the treatment of insomnia in patients with medical comorbidity.Dutch Trial Register NTR NL7971 . Registered on 18 August 2019." @default.
• W4200517196 created "2021-12-31" @default.
• W4200517196 creator A5013574301 @default.
• W4200517196 creator A5016255691 @default.
• W4200517196 creator A5016875427 @default.
• W4200517196 creator A5025018836 @default.
• W4200517196 creator A5031284865 @default.
• W4200517196 creator A5054464657 @default.
• W4200517196 creator A5057516561 @default.
• W4200517196 creator A5061815547 @default.
• W4200517196 creator A5065503974 @default.
• W4200517196 date "2021-12-01" @default.
• W4200517196 modified "2023-09-26" @default.
• W4200517196 title "TIMELAPSE study—efficacy of low-dose amitriptyline versus cognitive behavioral therapy for chronic insomnia in patients with medical comorbidity: study protocol of a randomized controlled multicenter non-inferiority trial" @default.
• W4200517196 cites W111186213 @default.
• W4200517196 cites W11283495 @default.
• W4200517196 cites W1436801937 @default.
• W4200517196 cites W1684861691 @default.
• W4200517196 cites W182910583 @default.
• W4200517196 cites W1867967591 @default.
• W4200517196 cites W190161614 @default.
• W4200517196 cites W1965581817 @default.
• W4200517196 cites W197066864 @default.
• W4200517196 cites W1972223942 @default.
• W4200517196 cites W1972519049 @default.
• W4200517196 cites W1987138256 @default.
• W4200517196 cites W1989617822 @default.
• W4200517196 cites W2006664993 @default.
• W4200517196 cites W2012435382 @default.
• W4200517196 cites W2014255786 @default.
• W4200517196 cites W2022191212 @default.
• W4200517196 cites W2027235889 @default.
• W4200517196 cites W2042185382 @default.
• W4200517196 cites W2043045906 @default.
• W4200517196 cites W2043059490 @default.
• W4200517196 cites W2047013630 @default.
• W4200517196 cites W2048458454 @default.
• W4200517196 cites W2051447719 @default.
• W4200517196 cites W2060806732 @default.
• W4200517196 cites W2061728401 @default.
• W4200517196 cites W2067000030 @default.
• W4200517196 cites W2083495357 @default.
• W4200517196 cites W2096230543 @default.
• W4200517196 cites W2101759370 @default.
• W4200517196 cites W2102471539 @default.
• W4200517196 cites W2121052523 @default.
• W4200517196 cites W2126710165 @default.
• W4200517196 cites W2140681667 @default.
• W4200517196 cites W2148760176 @default.
• W4200517196 cites W2158318448 @default.
• W4200517196 cites W2161493662 @default.
• W4200517196 cites W2166023752 @default.
• W4200517196 cites W2166281097 @default.
• W4200517196 cites W2171860213 @default.
• W4200517196 cites W2190174002 @default.
• W4200517196 cites W2309313861 @default.
• W4200517196 cites W2323457822 @default.
• W4200517196 cites W2418847208 @default.
• W4200517196 cites W2434919075 @default.
• W4200517196 cites W2444066881 @default.
• W4200517196 cites W2466726225 @default.
• W4200517196 cites W2587695521 @default.
• W4200517196 cites W2591465088 @default.
• W4200517196 cites W2612027047 @default.
• W4200517196 cites W2753866150 @default.
• W4200517196 cites W2795657325 @default.
• W4200517196 cites W2907884555 @default.
• W4200517196 cites W2930188897 @default.
• W4200517196 cites W2931923082 @default.
• W4200517196 cites W2967986432 @default.
• W4200517196 cites W4242707029 @default.
• W4200517196 cites W4247665917 @default.
• W4200517196 cites W4292994367 @default.
• W4200517196 doi "https://doi.org/10.1186/s13063-021-05868-4" @default.
• W4200517196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34895308" @default.
• W4200517196 hasPublicationYear "2021" @default.
• W4200517196 type Work @default.
• W4200517196 citedByCount "0" @default.
• W4200517196 crossrefType "journal-article" @default.
• W4200517196 hasAuthorship W4200517196A5013574301 @default.
• W4200517196 hasAuthorship W4200517196A5016255691 @default.
• W4200517196 hasAuthorship W4200517196A5016875427 @default.
• W4200517196 hasAuthorship W4200517196A5025018836 @default.
• W4200517196 hasAuthorship W4200517196A5031284865 @default.
• W4200517196 hasAuthorship W4200517196A5054464657 @default.
• W4200517196 hasAuthorship W4200517196A5057516561 @default.
• W4200517196 hasAuthorship W4200517196A5061815547 @default.
• W4200517196 hasAuthorship W4200517196A5065503974 @default.
• W4200517196 hasBestOaLocation W42005171961 @default.
• W4200517196 hasConcept C118552586 @default.
• W4200517196 hasConcept C126322002 @default.
• W4200517196 hasConcept C168563851 @default.
• W4200517196 hasConcept C1862650 @default.
• W4200517196 hasConcept C203092338 @default.
• W4200517196 hasConcept C2776245837 @default.
• W4200517196 hasConcept C2779159551 @default.
• W4200517196 hasConcept C2779783198 @default.
• W4200517196 hasConcept C2781210498 @default.
• W4200517196 hasConcept C2781265626 @default.
• W4200517196 hasConcept C2983189541 @default.

• next